Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Reuters
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceuticals Europe - Home | Facebook
Here's Why Teva Pharma Stock Is Soaring Today
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva sees higher margins, lower debt from restructuring | Financial Times
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Stock Skids As First-Quarter Sales Decline — Again | Investor's Business Daily
Teva is primed for a big bounce after years of underperformance, Barclays says
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
teva News and latest stories | The Jerusalem Post
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva Faces Rocky Path to Recovery After Debt | Fortune
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace
New York jury holds drug firm Teva liable in opioid crisis